2021 annual financial data
Nektar Therapeutics 2021 Operating margin
Direct answer
Operating margin was -437.76%.
Operating income was -446,103,000 USD and net income was -523,837,000 USD.
Operating cash flow was -412,660,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 101,907,000 USD
- Operating income
- -446,103,000 USD
- Net income
- -523,837,000 USD
- Operating cash flow
- -412,660,000 USD